Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT00019604
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed primary or metastatic liver lesions
* Not a candidate for surgical resection
* Must have six or fewer lesions and no single lesion greater than 7 cm in diameter
* Extrahepatic disease allowed
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* Eastern Cooperative Oncology Group (ECOG) 0-2
Life expectancy:
* At least 3 months
Hematopoietic:
* Platelet count at least 50,000/mm\^3
* Prothrombin time (PT) or partial thromboplastin time (PTT) no greater than 1.5 times control (except for therapeutically anticoagulated nonrelated medical conditions \[e.g., atrial fibrillation\])
Hepatic:
* Bilirubin no greater than 3.0 mg/dL
Renal:
* Creatinine no greater than 2.5 mg/dL
Other:
* Not pregnant or nursing
* Negative pregnancy test
* No pacemakers, cerebral aneurysm clips, shrapnel injury, or implantable electronic devices
* No known uncontrollable serious reactions (e.g., anaphylaxis) to contrast agents used in this study
* Weight less than 136 kg
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* Not specified
Other:
* Concurrent systemic therapy for extrahepatic disease is allowed only if begun prior to radiofrequency ablation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00019604
Study Brief:
Protocol Section:
NCT00019604